Quanterix (QTRX)
(Delayed Data from NSDQ)
$15.97 USD
-0.35 (-2.14%)
Updated May 31, 2024 04:00 PM ET
After-Market: $15.99 +0.02 (0.13%) 7:58 PM ET
2-Buy of 5 2
D Value F Growth B Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
QTRX 15.97 -0.35(-2.14%)
Will QTRX be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for QTRX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for QTRX
Wall Street Analysts Believe Quanterix (QTRX) Could Rally 67.66%: Here's is How to Trade
Quanterix Corporation (QTRX) Reports Q1 Loss, Tops Revenue Estimates
QTRX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Quanterix (QTRX) AD Offering Gets FDA's Breakthrough Device Tag
Quanterix Corporation (QTRX) Reports Q4 Loss, Tops Revenue Estimates
Quanterix (QTRX) Expands in Alzheimer's Testing With Alliances
Other News for QTRX
Quanterix to Present at Leerink Partners Healthcare Crossroads Conference 2024
Outperform Rating and $30 Price Target for Quanterix Amid Strong Position in Alzheimer’s Diagnostics Market
What's Driving Establishment Labs Holdings Inc's Surprising 34% Stock Rally?
Scotiabank Reaffirms Their Buy Rating on Quanterix (QTRX)
Quanterix Corp (QTRX) Q1 2024 Earnings Call Transcript Highlights: Robust Revenue Growth and ...